Compounds > spiperone
Page last updated: 2024-08-16

spiperone and carbostyril

spiperone has been researched along with carbostyril in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kikuchi, T; Nakata, Y; Segawa, T; Zhang, X1
Hirose, T; Kikuchi, T; Miwa, T; Morita, S; Oshiro, Y; Tottori, K; Uwahodo, Y1
Hide, I; Hirose, T; Inoue, A; Kikuchi, T; Koga, N; Nakata, Y; Seto, M; Sugita, S1
Burris, KD; Kikuchi, T; Molinoff, PB; Molski, TF; Ryan, E; Tottori, K; Xu, C; Yocca, FD1
Akaike, A; Izumi, Y; Kume, T; Matsuo, T; Sawada, H; Takada-Takatori, Y; Wakita, S1

Other Studies

5 other study(ies) available for spiperone and carbostyril

ArticleYear
Interactions of 7-[3-(4-[2,3-dimethylphenyl]piperazinyl)-propoxy]-2(1H)-quinolinone binding in rat striatum: effects of lesions.
    Pharmaceutical research, 1990, Volume: 7, Issue:3

    Topics: Animals; Benzazepines; Binding, Competitive; Corpus Striatum; Dopamine Agents; Hydroxydopamines; In Vitro Techniques; Kainic Acid; Male; Medial Forebrain Bundle; Oxidopamine; Piperazines; Quinolones; Rats; Rats, Inbred Strains; Spiperone

1990
7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 274, Issue:1

    Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Aripiprazole; Catalepsy; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Male; Mice; Mice, Inbred ICR; Motor Activity; Oxidopamine; Piperazines; Presynaptic Terminals; Quinolones; Radioligand Assay; Rats; Reserpine; Spiperone; Stereotyped Behavior; Synapses; Tritium

1995
Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary.
    Brain research. Molecular brain research, 1998, Volume: 55, Issue:2

    Topics: Administration, Oral; Animals; Antipsychotic Agents; Aripiprazole; Cell Membrane; Gene Expression Regulation; Haloperidol; Male; Piperazines; Pituitary Gland; Prolactin; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Ribonucleases; RNA, Messenger; Spiperone

1998
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Antipsychotic Agents; Aripiprazole; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; GTP-Binding Proteins; Humans; Piperazines; Quinolones; Radioligand Assay; Receptors, Dopamine D2; Signal Transduction; Spiperone

2002
Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport.
    European journal of pharmacology, 2010, Aug-25, Volume: 640, Issue:1-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Aripiprazole; Ascorbic Acid; Biological Transport; Dopamine; Extracellular Space; Gene Expression Regulation, Enzymologic; Haloperidol; Homovanillic Acid; Mesencephalon; Neurons; Pargyline; PC12 Cells; Pimozide; Piperazines; Quinolones; Rats; Spiperone; Transport Vesicles; Tyrosine 3-Monooxygenase

2010